A T-cell-dependent autoimmune model demonstrated that liraglutide, an earlier GLP-1 receptor agonist, inhibited T-cell proliferation and reduced disease severity
Its small molecular size allows it to penetrate intestinal epithelial cells directly, which is why it has attracted research interest as an orally deliverable gut-targeted compound
This supplement is not intended to diagnose, treat, cure, or prevent any disease
If you've tried diet and exercise without sustainable results or you're researching GLP-1 medications, metabolic peptides, or body-composition therapies a single consultation can clarify which path actually fits your physiology, your medical history, and your goals
When this occurs, additional free radicals are produced which, in turn, can result in more extensive damage to cells and tissues